Browse > Article
http://dx.doi.org/10.4333/KPS.2003.33.2.129

Effects of Vehicles and Penetration Enhancers on the Percutaneous Absorption of Apomorphine  

Choi, Young-Geun (College of Pharmacy, Sungkyunkwan University)
Cui, Yu (College of Pharmacy, Sungkyunkwan University)
Kim, Keun-Nam (College of Pharmacy, Sungkyunkwan University)
Park, Eun-Seok (College of Pharmacy, Sungkyunkwan University)
Chi, Sang-Cheol (College of Pharmacy, Sungkyunkwan University)
Publication Information
Journal of Pharmaceutical Investigation / v.33, no.2, 2003 , pp. 129-133 More about this Journal
Abstract
In order to evaluate the effects of vehicles and penetration enhancers on skin permeation of apomorphine, the skin permeation rates of apomorphine from vehicles of different composition were determined using Franz diffusion cells fitted with excised rat skins. Solubility of apomorphine in various solvents was investigated to select a vehicle suitable for the percutaneous absorption of apomorphine. The solvents used were propylene glycol (PG), $Transcutol^{\circledR},\;Labrasol^{\circledR},\;Labrafac hydro WL^{\circledR},\;Labrafil WL 2609 BS^{\circledR}$ and isopropyl alcohol. Even though permeation rates of apomorphine from each vehicle were low $(0.008-0.36\;{\mu}g/cm^2/hr)$, the combination of PG and $Labrafac^{\circledR}$ increased it significantly. The permeation rates of apomorphine from $PG/Labrafac^{\circledR}$ mixtures increased as the volume fraction of PG in the mixture increased. The maximum permeation rate of $18\;{\mu}g/cm^2/hr$ was achieved at 30% of PG, which decreased with further increase of PG fraction. A series of fatty acids, alcohols and monoterpenes were employed as penetration enhancers. Incorporation of each enhancer in the $PG/Labrafac^{\circledR}$ (30:70) mixture at the level of 10% improved the skin permeation significantly. The highest permeation rate, $117\;{\mu}g/cm^2/hr$, was attained with myristic acid.
Keywords
Apomorphine; Binary vehicle system; Enhancers; Percutaneous absorption;
Citations & Related Records
연도 인용수 순위
  • Reference
1 S.T. Gancher, Pharmacokinetics of apomorphine in Parkinson's disease, J. Neural. Transm., 45, 137-144 (1995)
2 A. Campell, N.S. Kula, B. Jeppson and R.J. Baldessarini, Oral bioavailability of apomorphine in the rats with a portocaval venous anastomosis, Eur. J. Pharmacol., 67, 139142 (1980)   DOI   ScienceOn
3 T. Van Laar, E.N. Jansen, A.W. Essink and C. Neef, Intranasal apomorphine in parkinsonian on-off fluctuations, Arch. Neurol., 49, 482-484 (1992)   DOI   ScienceOn
4 J.L. Montastruc, O. Rascol, J.M. Senard, V Gualano, H. Bagheri, G. Houin, A Lees and A. Rascol, Sublingual apomorphine in Parkinson's disease: a clinical and pharmacokinetic study, Clin. Neuropharmacol., 14,432-437 (1991).   DOI   ScienceOn
5 T. Van Laar, E.N. Jansen, A.W. Essink, W.J. Rutten and C.Neef, Rectal apomorphine: a new treatment modality in Parkinson's disease, J. Neural. Neurosurg. Psychiatry; 55, 737-738 (1992).
6 R. Van der Geest, M. Danhof and H.E. Bodde, Iontophoretic delivery of apomorphine. I: In vitro optimization and validation, Pharm. Res., 14, 1798-1803 (1997)   DOI   ScienceOn
7 P. Mayorga, F. Puisieux and G. Couarraze, Formulation study of a transdermal delivery system of primaquine, Int. J. Pharm., 132,71-79 (1996)   DOI   ScienceOn
8 H.S. Gwak and I. K. Chun, Effect of vehicles and penetration enhancers on the in vitro percutaneous absorption of tenoxicam through hairless mouse skin, Int. J. Pharm., 236, 57-64 (2002)   DOI   ScienceOn
9 B.J. Aungst, N.J. Rpgers and E. Shefter, Enhancement of naloxone penetration through human skin in vitro using fatty acids, fatty alcohols, surfactants, sulfoxide and amide, Int. J. Pharm., 33, 225-234 (1986)   DOI   ScienceOn
10 E.R. Cooper, E.W. Merrit. and R.L. Smith, Effect of fatty acids and alcohols on the penetration of acyclovir across human skin in vitro, J. Pharm. sa; 74, 688-689 (1985).   DOI
11 J. Yukawa,K. Sugibayashi and Y. Morimoto, Effect of various additives on the skin permeation of ketoprofen from the film forming transdermal formulation, Yakuzaigaku, 49, 254-262 (1989)
12 N. Yata, Recent studies on the absorption promoter, Pharm. Tech. Japan, 6, 13-27 (1989)
13 W.R. Pfister and D.S.T. Hseih, Permeation enhancers compatible with transdermal drug delivery systems, Pharm. Technol., 14, 132-140 (1990)
14 H. Sezaki, H. Okamoto and M. Hashida, Structure-activity relationship of l-alkyl- or I-alkenylazacycloalkanone derivatives as percutaneous penetration enhancers, J. Pharm. Sci., 77, 418-424 (1988)   DOI
15 D. Kobayashi, T. Matsuzawa, K. Sugibayashi, Y. Morimoto, M. Kobayashi and M. Kimura, Feasibility of use of several cardiovascular agents in transdermal therapeutic systems with l-menrhol-ethanol system on hairless rat and human skin, Biol. Pharm. Bull., 16, 254-258 (1993)   DOI   ScienceOn
16 H. Okabe, K. Takayama and T. Nagai, Percutaneous absorption of ketoprofen from acrylic gel patches containing d-limonene and ethanol as absorption enhancers, Chem. Pharm. Bull., 40, 1906-1910 (1992)   DOI   ScienceOn
17 M. Hori, S. Satoh, H.I. Maibach and R.H. Guy, Enhancement of propranolol hydrochloride and diazepam skin absorption in vitro: effect of enhancer lipophilicity, J. Pharm. Sci., 80, 32-35 (1991)   DOI
18 R. Van der Geest, T. Van Laar, J.M. Gubbens-Stibbe, H.E. Bodde and M. Danhof, Iontophoretic delivery of apomorphine. II: An in vivo study in patients with Parkinson's disease, Pharm. Res., 14, 1804-1810 (1997).   DOI   ScienceOn
19 E. Peira, P. Scolari and M.R. Gasco, Transdermal permeation of apomorphine through hairless mouse skin from microemulsions, Int. J. Pharm., 226,47-51 (2001)   DOI   ScienceOn
20 C.S. Leopold and B.C. Lippold, An attempt to clarify the mechanism of the penetration enhancing effects of lipophilic vehicles with differential scanning calorimetry(DSC), Pharm. Res., 10, S-245 (1993
21 B.M. Elyan, M.B. Sidhom and F.M. Plakogiannis, Evaluation of the effect of different fatty acids on the percutaneous absorption of metaproterenol sulfate, J. Pharm. Sci., 85, 101105 (1996)   DOI
22 D. Friend, P. Catz, J. Heller, J. Reid and R. Baker, Transdermal delivery of levonorgestrel: I. Alkanols as permeation enhancers in vitro, J. Control. Release, 7, 243-250 (1988)   DOI   ScienceOn